RhEumatiC Heart diseAse Genetics

CompletedOBSERVATIONAL
Enrollment

245

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Rheumatic Heart Disease
Interventions
GENETIC

Next generation sequencing

There will be no intervention. This is an observational trial to examine the differences in genetic variants and gene expression between patients with and without RHD.

Trial Locations (1)

Unknown

University of Rwanda, Kigali

All Listed Sponsors
collaborator

National University, Rwanda

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT02118818 - RhEumatiC Heart diseAse Genetics | Biotech Hunter | Biotech Hunter